Literature DB >> 14647688

[Choledochal cyst: a 10-year experience]

L H Pereira1, J M Bustorff-Silva, L Sbraggia-Neto, D G Bittencourt, G Hessel.   

Abstract

BACKGROUND: Choledochal cyst is a rare abnormality usually found in infancy and childhood and mainly in females. Outcome depends on early diagnosis, complete resection of the cyst and proper hepaticoenterostomy.
OBJECTIVE: The aim of this paper is to evaluate the outcome of 18 patients operated in ten years.
METHODS: Retrospective chart review. RESULTS AND DISCUSSION: Age ranged between 20 days and 13 years (mean 3 years). Fifteen (83%) were female and 03 (17%) male. Signs presented included 15 (83%) with jaundice, 11 (61%) with dark urine, 10(55%) with pale colored stools, 09 (50%) with abdominal pain and palpable mass in only 02(11%). Ultrasonography identified the cyst in 14 (77%) patients. Endoscopic retrograde cholangio-pancreatography demonstrated a long common duct in three of four cases. Anatomical types were: 09 type I, 01 type II, 07 type IV and 01 type V. Except for one patient who had a type V cyst, all patients underwent cyst resection plus Roux-en-Y hepaticojejunostomy. There were two (11%) early postoperative deaths related to deterioration of liver function. Thirteen (86%) of the 15 patients available to follow-up were symptom-free without late complications at a mean period of three years, and two (14%) patients developed chronic pancreatitis.

Entities:  

Year:  2000        PMID: 14647688     DOI: 10.2223/jped.54

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  2 in total

Review 1.  Choledochal cysts: part 2 of 3: Diagnosis.

Authors:  Janakie Singham; Eric M Yoshida; Charles H Scudamore
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

2.  Choledochal cysts: analysis of disease pattern and optimal treatment in adult and paediatric patients.

Authors:  Janakie Singham; David Schaeffer; Eric Yoshida; Charles Scudamore
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.